The Eleventh World Kidney Day (WKD) was marked on March 10, 2016 around the world. This annual event, sponsored jointly by the International Society of Nephrology (ISN) and the International Federation Foundation for Kidney Disease (IFKF), has become a very important way for the general public and the world's policy makers to learn about the importance of kidney disease and its consequences. This year's WKD was dedicated to children's kidney diseases, which may go beyond childhood and become adult kidney disease with possible complications for other organs (1) . The main motto of the 11th WKD was: "Act early to prevent it!" To achieve this very ambitious target, it is essential to lead a healthy life style from early childhood, and continuing through the whole life, to detect preventable kidney damage in time, and to treat children with inborn and acquired disorders of the kidney.
Acute and chronic kidney disease in childhood differ in comparison with those in adults. Also, significant differences exist within the pediatric population depending on age, and ethnic and regional affiliations, which are closely related to genetic and socioeconomic factors.
Acute kidney injury
The frequency of acute kidney injury (AKI) in childhood is highest in the first month of life, and then decreases progressively (2) . The predominant causes of pediatric AKI vary in different regions of the world (3). The common occurrence of infections and gastroenteritis, leading to severe dehydration and subsequent acute tubular necrosis are the main factors for AKI in rural developing-country setting. By contrast, the complications of very sophisticated medical treatment, such as cardiac surgery, chemotherapy, and organ and bone marrow transplant, have become more prevalent AKI causes in tertiary care units in developed countries in recent years (4) (5) (6) . The mortality rate in children with AKI is considered to depend largely on the nature of the underlying disease and the availability of resources to treat AKI. Mortality is usually very high (up to 90%) in patients with AKI related to multi-organ failure, while survivors often suffer from irreversible complications (7). In tertiary-intensive care pediatric unit patients, ∼10% develop chronic kidney disease (CKD) 1-3 years after AKI (8) .
To improve the outcome of AKI in general, early diagnosis is essential, which will likely achieved by the use of new biomarkers, such as neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, interleukin 18 and liver-type fatty acid binding protein (9) . To address the problem of AKI treatment in the developing nations of sub-Saharan Africa and South East Asia, the ISN initiated the Saving Young Lives Project, which aims both to prevent AKI with prompt treatment of infection and/or delivery of appropriate fluid and electrolyte therapy, and to treat AKI when it occurs, including the provision of acute peritoneal dialysis (1) . It is expected that the Project activities will ensure by 2025 that nobody will die from preventable and acute kidney injury (1).
Chronic kidney disease
The existing epidemiological data on CKD in children mainly focus on renal replacement therapy (RRT), which covers only part of the population suffering from CKD during childhood, as a considerable number of children with renal impairment will reach endstage renal disease (ESRD) in adulthood. The prevalence of ESRD in childhood has been variously reported as 15 to 74.7 per million children (10) . It constitutes only a few percent of the total ESRD patient population (11) . In contrast to adult CKD, which is predominately caused by diabetic nephropathy, hypertension, and autosomal dominant polycystic kidney disease, the main causes of pediatric CKD are congenital anomalies of the kidney and urinary tract (CAKUT) at approximately 50%, followed by hereditary nephropathies and glomerulonephritis (10, 11) . Unlike in adults, CKD in children is manifested by growth and development disorders. Further, the life expectancy of children with CKD is longer than in adult patients. Therefore, more intensive therapy is required to slow the progression of CKD. The last decade has witnessed enormous achievements in this field. In addition to standard renoprotective therapy that works by normalization of blood pressure, proteinuria, hyperphosphataemia, anemia and hyperuricemia, new drugs offer great hope (Table 1) (12) .
According to the ESCAPE trial data, strict blood pressure control (∼ 5othpercen-tile) retards progression of CKD in children, irrespective of the type of underlying kidney disease (13) . Vitamin D may also promote renoprotection by suppressing renin transcription through cross-talk between RAAS and vitamin D-fibroblast growth factor-23 (FGF-23)-Klotho pathways (14) . In line with the latest findings on the role of inflammation in the progression of CKD, therapeutic blockade of leucocytes chemokine receptors inhibits secretion of the pro inflammatory, pro apoptotic and pro fibrotic cytokines that perpetuate renal tissue destruction (12) . The role of the gut as a major source of inflammation adds also a novel therapeutic tool, healthy nutrition, to delay CKD progression.
Very recently, progress in drug development in line with advances in genetics, have given hope for some kidney diseases including atypical HUS, (with the advent of a monoclonal antibody that specifically blocks C5 activation) (15) , polycystic kidney disease (vasopressin receptor antagonists retard cyst growth and preserve kidney function) (16) , and primary and secondary amyloidosis (IgG anti-Serum amyloid protein antibodies clears tissue amyloid deposits) (12) . However, the benefit from modern therapy is not available to all children who need it because of the high cost of the drugs. Even RRT is not available to all children with ESRD. In developing countries, dialysis is often not offered, while undeveloped cadaveric transplantation might lead to trade in paid organ donation. The WKD provides the ideal opportunity to detect and discuss these and many other problems related to kidney diseases, and to initiate comprehensive action to resolve them.
Conclusion
The Eleventh WKD is a global alertness and education campaign that highlights renal disease and children. The general message is "a collaborative modality against the renal diseases in children that lead to endstage renal failure, through increasing community outreach, improved economic opportunity, better education, and access to preventive strategies for individuals at highest risk." 
